Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Muriuki, Beatrice Mukami ^a   Gicheru, Michael Muita ^a   Wachira, Dorcas ^b   Nyamache, Anthony Kebira ^a,b   Khamadi, Samoel Ashimosi ^b  

^a KENYATTA UNIVERSITY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

ELISA; Hepatitis; HIV 1

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; BLOOD; CHILD; EPIDEMIOLOGY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFANT; KENYA; MALE; MIDDLE AGED; MIXED INFECTION; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; KENYA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84883549377     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-363     Document Type: Article

References (53)

1. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. Saravanan S, Velu V, Kumarasamy N, Nandakumar S, Murugavel K, et al. World J Gastroenterol 2007 13 5015 5020 17854146 (Pubitemid 47496836)
2. Viral hepatitis in HIV infection. Koziel M, Peters M, N Engl J Med 2007 356 1445 1454 10.1056/NEJMra065142 17409326 (Pubitemid 46556329)
3. Hepatitis C and HIV co-infection: a review. Maier I, Wu G, World J Gastroenterology 2002 8 577 579 (Pubitemid 34918644)
4. Global estimates of prevalence of HCV infection among injecting drug users. Aceijas C, Rhodes T, Int J Drug Policy 2000 18 352 358
5. Hepatitis B and human immunodeficiency virus coinfection. Thio C, Hepatology 2009 49 138 145 10.1002/hep.22883
6. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, et al. Clin Infect Dis 2009 48 1763 1771 10.1086/599110 19435436
7. Drug resistance and immune escape HBV mutants in HIV-infected hosts. Lacombe K, Boyd A, Gozlan J, Lavocat F, Girard PM, Zoulim F, Antivir Ther 2010 15 493 497 10.3851/IMP1495 20516570
8. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. Sulkowski MS, Thomas DL, Chaisson RE, et al. JAMA 2000 283 1 74 80 10.1001/jama.283.1.74 10632283 (Pubitemid 30038386)
9. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Sulkowski MS, Thomas DL, Mehta SH, et al. Hepatology 2002 35 1 182 189 10.1053/jhep.2002.30319 11786975 (Pubitemid 34032559)
10. Safety and efficacy of adefovir dipivoxil in patients coinfected with HIV-1 and lamivudine-resistant HBV: an open-label pilot study. Benhamou Y, Bochet M, Thibault V, et al. Lancet 2001 358 718 723 10.1016/S0140-6736(01) 05840-8 11551579 (Pubitemid 32823401)
11. Current status and future directions in the management of chronic hepatitis C. Gamal S, Mousa SA, Virol J 2012 9 57 10.1186/1743-422X-9-57 22385500
12. Treatment of chronic hepatitis B: Evolution over two decades. Man-Fung Y, Ching-Lung L, J Gastroenterol Hepatol 2011 26 Suppl. 1 138 143 21199525
13. Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, et al. PLoS ONE 2008 3 10 3608 10.1371/journal.pone.0003608 18974888
14. Prevalence of hepatitis c virus and its genotypes among a cohort of drug users in Kenya. Muasya T, Lore W, Yano K, Yatsuhashi H, Owit FR, Fukuda M, Tamada MY, Kulundu J, Tukei J, Okoth FA, East Afr Med J 2008 85 7
15. Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region. Zhou Y-H, Liu F-L, Yao Z-H, Duo L, Li H, et al. PLoS ONE 2011 6 1 16349 10.1371/journal.pone.0016349 21283696
16. Application of flow cytometry to the study of HIV infection. Landay A, Ohlsson-Wilhelm B, Giorgi J, AIDS 1990 4 479 497 10.1097/00002030-199006000- 00001 2201315 (Pubitemid 20215018)
17. Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assays. Zaaijer H, Vrielink H, Koot M, Vox sang 2001 81 219 221 10.1046/j.1423-0410.2001.00110.x 11903996 (Pubitemid 36806481)
18. Diagnostic tests for hepatitis C. Gretch DR, Hepatology 1997 26 43 47
19. HIV, hepatitis B, and hepatitis C in Zambia. Kapembwa KC, Goldman JD, Lakhi S, Banda Y, Bowa K, Vermund SH, Mulenga J, Chama D, Chi BH, J Global Infect Dis 2011 3 269 274 10.4103/0974-777X.83534
20. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. Nagu T, Bakari M, Matee M, BMC Publ Health 2008 8 416 10.1186/1471-2458-8-416
21. Hepatitis C virus (HCV) infection in Africa: a review). Karoney MJ, Siika AM, Pan Afr Med J 2013 14 44 doi:0.11604/pamj.2013.14.44.2199. Epub 2013 Jan 31 23560127
22. HIV, hepatitis B and C co-infection in Kenya. Harania R, Karuru J, Nelson M, Stebbing J, AIDS 2008 22 1221 1222 10.1097/QAD.0b013e32830162a8 18525268
23. Hepatitis B, hepatitis C, and HIV-1 coinfection in two selected informal urban settlements in Nairobi, Kenya. Kerubo G, Khamadi SA, Mwau M, Madise N, Azeh A, AIDS 2010-XVIII International AIDS Conference Abstract no. CDB0093 24014940
24. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, et al. J Med Virol 2004 74 34 40 10.1002/jmv.20143 15258966 (Pubitemid 38988857)
25. Hepatitis C virus prevalence and serotypes associated with HIV in The Gambia. Mboto CI, Fielder M, Davies-Russell A, Jewell AP, Br J Biomed Sci 2010 67 140 144 20973409
26. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection. Moore E, Beadsworth MB, Chaponda M, Mhango B, Faragher B, Njala J, et al. J Infect 2010 61 155 163 10.1016/j.jinf.2010.04.009 20470823
27. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Hart IJ, Munthali C, et al. J Infect 2008 57 72 77 10.1016/j.jinf.2008. 05.004 18555534
28. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, et al. Ann Hepatol 2008 7 152 156 18626434 (Pubitemid 351845527)
29. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. Pirillo MF, Bassani L, Germinario EA, Mancini MG, Vyankandondera J, Okong P, et al. J Med Virol 2007 79 1797 1801 10.1002/jmv.21007 17935164 (Pubitemid 350006301)
30. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H, Toure-Kane C, Etard JF, Lo G, Diaw P, Ngom-Gueye NF, et al. J Med Virol 2008 80 1332 1336 10.1002/jmv.21236 18551596 (Pubitemid 351897402)
31. Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa. Kallestrup P, Zinyama R, Gomo E, Dickmeiss E, Platz P, Gerstoft J, et al. AIDS 2003 17 1400 1402 10.1097/00002030-200306130-00019 12799566 (Pubitemid 36819859)
32. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending te paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. Telatela S, Mecky MA, Munubhi E, BMC Publ Health 2007 7 338 10.1186/1471-2458-7- 338
33. Prevalence of hepatitis viruses in an anti-Human Immunodeficiency Virus positive population from Argentina- A multicentre study. Fainboim H, Gonzalez J, Fassio P, J viral Hepatology 1999 6 53 57 28 10.1046/j.1365-2893.1999.00005.x (Pubitemid 29349791)
34. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Oshitani H, Kasolo FC, Mpabalwani M, Mizuta K, Luo NP, Suzuki H, et al. Trans R Soc Trop Med Hyg 1996 90 235 236 10.1016/S0035-9203(96)90227-8 8758060 (Pubitemid 26188858)
35. HIV-HBV coinfection among South African patients receiving antiretroviral therapy. Di Bisceglie AM, Maskew M, Schulze D, Reyneke A, McNamara L, Firnhaber C, Antivir Ther 2010 15 3 Pt B 499 503 45 20516571
36. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. Belay T, Gizachew Y, Afework K, Anteneh A, Andargachew M, Frank E, Ulrich S, BMC Infect Dis 2010 10 111 10.1186/1471-2334-10-111 20459703
37. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ, J Med Virol 2009 81 406 412 10.1002/jmv.21418 19152393
38. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Lesi OA, Kehinde MO, Oguh DN, Amira CO, Niger Postgrad Med J 2007 14 2 129 133 17599111
39. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath, Johannesburg. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I, East Afr Med J 2000 77 1 13 15 10944831
40. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson RE, et al. Clin Infect Dis 2008 47 1479 1485 10.1086/593104 18937580
41. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Shimelis T, Torben W, Medhin G, Tebeje M, Andualm A, Demessie F, et al. Sex Transm Infect 2008 84 37 41 10.1136/sti.2007.027326 17804606 (Pubitemid 351195851)
42. Prevalence of Bloodborne Infectious Diseases in blood donors in Ghana. Ampofo W, Nii-Trebi N, Ansah j, Abe K, Naito H, Aidoo S, Nuvor V, Brandful J, Yamamoto N, Ofori-Adjei D, Ishikawa K, J Clinical Microbiology 2002 40 3523 3525 10.1128/JCM.40.9.3523-3525.2002 (Pubitemid 34977485)
43. Seroprevalence of hepatitis B markers in pregnant women in Kenya. Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, Esamai F, Alavi Z, Otieno J, Kiambati H, Wanjuki N, East Afr Med J 2006 83 485 493 17447350
44. HIV co-infection at Kisumu district hospital, Kenya. Otedo AEHBV, East Afr Med J 2004 81 12 626 630 15868977
45. The Prevalence of Hepatitis B surface Antigenaemia in HIV positive patients in the Niger Delta Nigeria. Ejele OA, Nwauche CA, Erhabor O, Niger J Med 2004 13 2 175 179 15293840
46. The prevalence of hepatitis B surface antigenaemia in patientys with Human Immunodeficiency virus (HIV) infection in Gombe, Nigeria. Mustapha S, Jibrin Y, Annual African Medical J 2004 3 10 12
47. Kasolo F, Sakala I, Baboo K, Hepatitis B virus infection in human immunodeficiency virus seropositive patients at the University Teaching Hospital, Lusaka, Zambia: Interrelationship. [Abstract no. 963]. 2 nd IAS Paris, France: Conference on HIV Pathogenesis and Treatment 2003
48. Hepatitis B virus co-infection in HIV infected patients. Sud A, Singh J, Dhiman RK, Wanchu A, Singh S, Chawia Y, Trop Gastroenterol 2001 22 2 90 92 11552493
49. Infection with HIV, Syphilis and hepatitis B in Ethiopia: A survey in blood donors. Rahlenbeck S, Yohannes G, Molla K, Reifen R, Assefa A, Int J STDS AIDS 1997 8 261 264 10.1258/0956462971919886 (Pubitemid 27192083)
50. Prevalence of Hepatitis B Virus (HBV) surface antigen and HBV-associated hepatocellular carcinoma in Kenyans of various ages. Mutuma GZ, Mbuchi MW, Zeyhle E, Fasana R, Okoth FA, Kabanga MJ, Kuria J, Shiramba LT, Njenga KM, Kaiguri PM, Osidiana V, Afr J Health Sci 2011 18 53 61
51. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Wester CW, Bussmann H, Moyo S, Avalos A, Gaolathe T, Ndwapi N, et al. Clin Infect Dis 2006 43 1612 1615 10.1086/508865 17109297 (Pubitemid 44901905)
52. HIV, Hepatitis B and C viruses' coinfection among patients in a Nigerian tertiary hospital. Taiwo Modupe B, Samuel E, Emmanuel Folorunso O, Pan African Medical J 2012 12 100
53. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. Firnhaber C, Reyneke A, Schulze D, Malope B, Maskew M, MacPhail P, et al. S Afr Med J 2008 98 541 544 18785395